𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Cost-effectiveness Analysis of Two Rehabilitation Support Services for Women with Breast Cancer

✍ Scribed by Louisa G. Gordon; Paul Scuffham; Diana Battistutta; Nick Graves; Margaret Tweeddale; Beth Newman

Publisher
Springer US
Year
2005
Tongue
English
Weight
299 KB
Volume
94
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of a peer support program for
Evaluation of a peer support program for women with breast cancer—lessons for practitioners
✍ Jeffrey Dunn; Suzanne K. Steginga; Stefano Occhipinti; Keithia Wilson 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

The present study aimed to describe how a volunteer peer support service assists women with breast cancer, and provides guidelines for practitioners in the development and implementation of such programmes. A two-phase evaluation of a breast cancer peer support program was undertaken to describe imp

Cost-effectiveness of switching to exeme
Cost-effectiveness of switching to exemestane versus continued tamoxifen as adjuvant therapy for postmenopausal women with primary breast cancer
✍ Nancy A. Risebrough; Shailendra Verma; Maureen Trudeau; Nicole Mittmann 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Abstract ## BACKGROUND. Sequential tamoxifen/exemestane therapy reportedly improves disease‐free survival in women with primary breast cancer compared with continued tamoxifen therapy. The objective of the current study was to assess the cost‐effectiveness of switching to exemestane after 2 to

Centralization of care for patients with
Centralization of care for patients with advanced-stage ovarian cancer : A cost-effectiveness analysis
✍ Robert E. Bristow; Antonio Santillan; Teresa P. Diaz-Montes; Ginger J. Gardner; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 2 views

## Abstract ## BACKGROUND. The objective of this study was to evaluate the cost‐effectiveness of centralized referral of patients with advanced‐stage epithelial ovarian cancer who underwent primary cytoreductive surgery and adjuvant chemotherapy. ## METHODS. A decision‐analysis model was used to

Cost-effectiveness analysis of trastuzum
Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer
✍ Louis P. Garrison Jr; Deborah Lubeck; Deepa Lalla; Virginia Paton; Amylou Dueck; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

## Abstract ## BACKGROUND. Adding trastuzumab to adjuvant chemotherapy provides significant clinical benefit in patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer. A cost‐effectiveness analysis was performed to assess clinical and economic implications of adding t